Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study record content with an access-denied screen. The header and footer remain, but the study details are not accessible.SummaryDifference16%

- Check52 days agoChange DetectedAdds 'Schizophrenia' and 'MedlinePlus Genetics' to the related topics. The revision tag updates from v3.6.5 to v3.6.6, indicating a version change.SummaryDifference0.1%

- Check66 days agoChange DetectedSchizophrenia and MedlinePlus Genetics entries were removed from the MedlinePlus related topics on the page. This shortens the list of contextual topic links presented to users without altering core study information.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now lists Schizophrenia as the study condition and adds related topics with a MedlinePlus Genetics link. The revision has been updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.